CJC-1295 10mg, Ipamorelin 10mg (20mg Blend)

$109.99

    • CJC-1295 (No DAC): 10mg
    • Ipamorelin: 10mg
    • Total Material: 20mg
    • Vial Size: 3mL
    • CJC Molecular Formula: C152H252N44O42
    • CJC Molecular Weight: 3367.9 g/mol
    • CJC PubChem CID: 56841945
    • Ipamorelin Molecular Formula: C38H49N9O5
    • Ipamorelin Molecular Weight: 711.9 g/mol
    • Ipamorelin PubChem CID: 9831659
    • Intended Use: Controlled laboratory research only

50 in stock

SKU: LPCJCIPA20 Categories: , Tags: ,
Description

CJC-1295 No DAC 10mg / Ipamorelin 10mg – Advanced 20mg Research Blend

CJC-1295 No DAC 10mg / Ipamorelin 10mg is a two-component research blend containing 20mg total specified material in a 3mL vial. Equal listed quantities of the two research materials provide a clearly documented formulation for controlled laboratory investigation.

Each component has separately supplied sequence, molecular formula, molecular weight, and PubChem information for research identification and documentation.

CJC-1295 No DAC / Ipamorelin Research Blend

The formulation contains two independently specified components:

Specification No DAC Component Ipamorelin
Quantity 10mg 10mg
Molecular Formula C152H252N44O42 C38H49N9O5
Molecular Weight 3367.9 g/mol 711.9 g/mol
PubChem CID 56841945 9831659

Total Material: 20mg
Vial Size: 3mL

These values describe the supplied research product. They do not establish a human dose, administration schedule, or experimental concentration.

Molecular Specifications of the No DAC Component

The supplied sequence is:

H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

Its molecular formula is:

C152H252N44O42

The supplied molecular weight is 3367.9 g/mol, while the PubChem CID is 56841945.

These characteristics provide reference points for material identification and laboratory documentation.

No CAS number was supplied for this component, so one is not being inferred.

Ipamorelin 10mg Molecular Specifications

The second component contains 10mg of Ipamorelin.

Its supplied sequence is:

H-Aib-His-D-2Nal-D-Phe-Lys-NH2

The molecular formula is C38H49N9O5, with a supplied molecular weight of 711.9 g/mol and PubChem CID 9831659.

Researchers can examine the supplied formula through the PubChem Ipamorelin molecular formula search.

No CAS number was provided with the supplied product information, so none is being added.

Two-Component 20mg Research Formulation

This research blend contains:

No DAC component: 10mg
Ipamorelin: 10mg

Together, the two quantities provide 20mg total specified material.

Because this is a combination product, research involving either material independently should be distinguished from research involving the complete formulation.

Experimental observations from an isolated component should not automatically be generalized to a multi-component research system.

Molecular Identification

Reliable material identification should use the complete molecular specifications rather than product naming alone.

For the first component, the supplied information includes its full sequence, formula C152H252N44O42, molecular weight of 3367.9 g/mol, and PubChem CID 56841945.

For the second component, researchers have the supplied sequence, formula C38H49N9O5, molecular weight of 711.9 g/mol, and PubChem CID 9831659.

These characteristics can be documented alongside experimental conditions when comparing research materials with scientific records.

3mL Research Vial Format

The complete 20mg blend is supplied in a 3mL vial.

The vial capacity is a physical product specification. It does not establish a final preparation volume, experimental concentration, or administration volume.

No preparation solvent, reconstitution procedure, or experimental concentration was supplied in the provided product information.

Those parameters should therefore not be inferred from the vial size.

Laboratory Research Considerations

Controlled research involving this two-component formulation should account for both specified materials.

Relevant considerations may include:

  • Identity of each component
  • Individual material quantities
  • Molecular characteristics
  • Experimental concentration
  • Research model
  • Appropriate controls
  • Exposure conditions
  • Analytical methodology
  • Experimental endpoints
  • Reproducibility
  • Data interpretation

Research conclusions should remain limited to the experimental conditions and models actually investigated.

Experimental Documentation

Detailed records can help researchers distinguish observations involving individual materials from those involving a combination.

Laboratory documentation may include:

  • Product name
  • Individual component quantities
  • Total material
  • Molecular sequences
  • Molecular formulas
  • Molecular weights
  • PubChem identifiers
  • Vial capacity
  • Experimental concentration
  • Research model
  • Controls
  • Analytical methods
  • Experimental endpoints

Clear documentation is particularly useful when multiple materials are included in a single formulation.

Evaluating Scientific Literature

Researchers reviewing scientific publications should determine whether the study examines an individual component or a combination.

Relevant comparison factors include:

  • Exact molecular identity
  • Research model
  • Experimental concentration
  • Study design
  • Controls
  • Exposure conditions
  • Analytical methodology
  • Measured endpoints

A study involving one isolated material should not automatically be considered evidence for the complete blend.

Likewise, differences in experimental methodology can limit direct comparison between studies.

CJC-1295 Research Identification

The supplied product name identifies the first component as CJC-1295 (No DAC).

Researchers may encounter alternative formatting such as cjc 1295, cjc1295, or punctuation variations in database and search queries.

These formatting differences should not replace molecular verification. Sequence and molecular specifications provide more precise reference points when comparing research materials.

For SEO purposes, this page uses the standard hyphenated product terminology while avoiding unnecessary repetition of nearly identical keyword variations.

Related OROS Research Materials

Researchers can review PT-141 10mg as another independently specified research material.

Another catalog option is Selank N-Acetyl Amidate 10mg.

Researchers interested in a spray-format material can explore Selank N-Acetyl Amidate Spray 20mg.

Another separately specified research material is Semax N-Acetyl Amidate 30mg.

Each product has independent specifications and should be evaluated according to its own molecular and experimental characteristics.

Scientific Research Resources

Researchers can use PubChem to investigate available molecular records and chemical identifiers.

Peer-reviewed biomedical and experimental literature can be searched through PubMed.

The exact compound or combination, molecular identity, research model, methodology, controls, and experimental endpoints should be verified before comparing findings between studies.

Research FAQ

What does this research blend contain?

The formulation contains 10mg of CJC-1295 (No DAC) and 10mg of Ipamorelin, providing 20mg total specified material.

How much of each component is supplied?

Each component contributes 10mg to the formulation.

What is the PubChem CID of the No DAC component?

The supplied PubChem CID is 56841945.

What is the Ipamorelin PubChem CID?

The supplied identifier is 9831659.

What is the total material quantity?

The two listed components provide 20mg total material.

What size vial is supplied?

The formulation is supplied in a 3mL vial.

Does the 3mL vial determine research concentration?

No. Vial capacity does not independently establish experimental concentration or preparation volume.

Are CAS numbers supplied?

No CAS numbers were included in the supplied specifications for either component, so none are being inferred.

Research Use Disclaimer

This CJC-1295 No DAC / Ipamorelin blend is presented exclusively for controlled laboratory investigation, analytical evaluation, and applicable in-vitro research. Material quantities and vial capacity are product specifications and do not constitute human dosing or administration guidance. This information does not provide instructions for injection, self-administration, therapeutic use, diagnosis, treatment, bodybuilding, performance enhancement, or veterinary application.

Additional information
Net Weight

20mg

Brand

OROS Research

Format

Lyophilized Vial

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 10mg, Ipamorelin 10mg (20mg Blend)”

Your email address will not be published. Required fields are marked *